Pregnancy in systemic sclerosis (SSc): results of systematic review and meta-analysis.
Through a systemic literature research (SLR) and meta-analysis, to determine maternal and foetal outcomes in SSc pregnancies, to analyse the effect of pregnancy on disease activity and to explore predictors of foetal and maternal outcomes. A SLR was performed for articles on SSc and pregnancy published between 1950 and 1st February 2018. Reviewers double extracted articles to obtain agreement on>95% of pre-defined critical outcomes. 461 publications were identified, 16 were included in the meta-analysis. The metanalysis showed that SSc pregnancies were at higher risk of miscarriages (OR 1.6,CI95% 1.22-2.22), foetuses with intrauterine growth retardation (IUGR) (OR 3.2,CI95% 2.21-4.53), preterm births (OR 2.4,CI95% 1.14-4.86) and newborns with low birth weight (OR 3.8,CI95% 2.16-6.56). SSc patients had 2.8 times higher chance of developing gestational hypertension (OR 2.8,CI95% 2.28-3.39) and 2.3 times higher chance of having Caesarean delivery compared to controls (OR 2.3,CI95% 1.37-3.8). The definitions of disease worsening/new visceral organ involvement were too inexact to have any confidence in the results although there were said to be worsening or new disease manifestations during pregnancy in 44/307(14.3%) cases and during the 6-months post-partum in 32/306(10.5%) cases. The data did not permit definition of predictors of disease progression and of maternal and foetal outcomes. SSc pregnancies have increased frequency of miscarriages, IUGR, pre-term deliveries and newborns with low birth weight compared to healthy controls. SSc women were more prone to develop gestational hypertension and to undergo Caesarean section. Disease manifestations seem to remain stable or improve in most patients.